Antisense Therapeutics Limited
ATHJFOTCHealthcare
$0.01
$-0.04(-76.00%)
Market Cap$19635001
P/E Ratio—
52W High$0.075
52W Low$0.01
Antisense Therapeutics Limited（ATHJF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ATHJF · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-06 | 2023-06 | 2022-06 | 2021-06 | 2020-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.97M | $1.58M | $1.78M | $0.58M | $0.67M |
| Cost of Revenue | $0.06M | $0.10M | $0.09M | $0.10M | $0.11M |
| Gross Profit | $2.91M | $1.48M | $1.69M | $0.47M | $0.56M |
| Gross Margin %(computed) | 97.91% | 93.97% | 94.98% | 82.12% | 83.90% |
| Operating Expenses | |||||
| R&D Expenses | $10.70M | $10.16M | $4.54M | $4.91M | $1.90M |
| G&A Expenses | $0.55M | $3.05M | $2.92M | $3.56M | $4.46M |
| Total Operating Expenses | $14.74M | $13.34M | $7.61M | $8.68M | $6.67M |
| Operating Income | ($11.83M) | ($13.34M) | ($7.61M) | ($8.68M) | ($6.67M) |
| Operating Margin %(computed) | -398.65% | -844.70% | -428.10% | — | -997.30% |
| Interest Income | $0.62M | $0.38M | $0.03M | $0.00M | $0.03M |
| Interest Expense | $0.00M | $0.01M | $0.01M | $0.01M | $0.01M |
| Income Before Tax | ($11.92M) | ($11.38M) | ($5.81M) | ($8.06M) | ($5.91M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($11.92M) | ($11.38M) | ($5.81M) | ($8.06M) | ($5.91M) |
| Net Margin %(computed) | -401.57% | -720.31% | -326.89% | — | -883.89% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.01 | $-0.02 | $-0.01 | $-0.01 | $-0.01 |
| Wtd Avg Shares | 881.21M | 668.85M | 631.79M | 540.98M | 454.51M |
| EBITDA | ($11.90M) | ($11.37M) | ($5.83M) | ($8.10M) | ($5.99M) |
| EBITDA Margin %(computed) | -400.93% | -719.53% | -327.74% | — | -896.72% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · AUD · M
深入了解Antisense Therapeutics Limited
关于Antisense Therapeutics Limited（ATHJF）损益表
Antisense Therapeutics Limited（ATHJF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，ATHJF实现营收$0.00B，毛利润$0.00B（毛利率97.91%），净利润($0.01B)（净利率-401.57%）。
常见问题
ATHJF · 4 问Antisense Therapeutics Limited（ATHJF）2024财年营收为$0.00B，同比up87.9%。
ATHJF revenueATHJF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08